Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years

被引：0
作者：
Eduardo A. Oliveira
Maria Christina L. Oliveira
Ana Cristina Simões e Silva
Enrico A. Colosimo
Robert H. Mak
Mariana A. Vasconcelos
Ludmila R. Silva
Daniella B. Martelli
Clara C. Pinhati
Hercílio Martelli-Júnior
机构：
[1] Federal University of Minas Gerais (UFMG),Department of Pediatrics, Health Sciences Postgraduate Program, School of Medicine
[2] Federal University of Minas Gerais,Department of Statistics
[3] Rady Children’s Hospital,Department of Pediatrics
[4] University of California,Health Science/Postgraduate Program in Nursing. School of Nursing
[5] Federal University of Minas Gerais (UFMG),Health Science/Primary Care Postgraduate Program
[6] State University of Montes Claros (Unimontes),undefined
来源：
World Journal of Pediatrics | 2023年 / 19卷
关键词：
Children; COVID-19; Effectiveness; Omicron; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：949 / 960
页数：11
相关论文
共 204 条
  • [1] Watson OJ(2022)Global impact of the first year of COVID-19 vaccination: a mathematical modelling study Lancet Infect Dis 22 1293-1302
  • [2] Barnsley G(2021)Expert consensus on COVID-19 vaccination in children World J Pediatr 17 449-457
  • [3] Toor J(2022)Evaluation of mRNA-1273 Covid-19 vaccine in children 6 to 11 years of age N Engl J Med 386 2011-2023
  • [4] Hogan AB(2022)Evaluation of the BNT162b2 covid-19 vaccine in children 5 to 11 years of age N Engl J Med 386 35-46
  • [5] Winskill P(2022)Safety of COVID-19 vaccination in US children ages 5–11 years Pediatrics 150 e2022057313-284
  • [6] Ghani AC(2022)Role of omicron variant of SARS-CoV-2 in children in Germany World J Pediatr 18 283-2219
  • [7] Zheng YJ(2022)Vaccine effectiveness of BNT162b2 against delta and omicron variants in adolescents Pediatrics 150 e2022057634-428
  • [8] Wang XC(2022)Association of prior BNT162b2 COVID-19 vaccination with symptomatic SARS-CoV-2 infection in children and adolescents during omicron predominance JAMA 327 2210-358
  • [9] Feng LZ(2022)Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) mRNA vaccine in preventing SARS-CoV-2 infection among children aged 5–11 years and adolescents aged 12–15 years - PROTECT cohort, July 2021-February 2022 MMWR Morb Mortal Wkly Rep 71 422-236
  • [10] Xie ZD(2022)Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing covid-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5–17 years - VISION network, 10 states, April 2021-January 2022 MMWR Morb Mortal Wkly Rep 71 352-532
12345678910